Enterprise Value is a firm valuation proxy that approximates current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Aegerion
Enterprise Value
=
Market Cap + Debt
-
Cash
=
1.18 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
In accordance with recently published financial statements Aegerion Pharmaceuticals Inc has Current Valuation of 1.18 B. This is 94.77% lower than that of Healthcare sector, and 99.46% lower than that of Drug Manufacturers - Major industry, The Current Valuation for all stocks is 95.97% higher than the company.
Filter other Stocks by Current Valuation
Specify Market Cap
Select Current Valuation Range
Current Range
Indicate Industry
Click to run this filter
Filter Other Equities
Aegerion Pharmaceuticals Inc is rated below average in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Drug Manufacturers - Major industry is presently estimated at about 1.29 Trillion. Aegerion adds roughly 1.18 Billion in current valuation claiming only tiny portion of equities under Drug Manufacturers - Major industry.
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
Nasdaq Aegerion Pharmaceuticals Inc
-0.29%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
